EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Single-cell genomics analysis reveals complex genetic interactions in an in vivo model of acquired BRAF inhibitor resistance

Jacob L Schillo iD, Charlotte R Feddersen, Rebekah M Peplinski, Lexy S Powell, Afshin Varzavand, Christopher S Stipp, Jesse D Riordan, Adam J Dupuy iD

NAR Cancer · 09.01.2024 · 6 (1)

DOI: 10.1093/narcan/zcad061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NAR Cancer, online erschienen am 11.01.2024. Verfasst von Jacob L Schillo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy & Cell Biology, Carver College of Medicine, The University of Iowa, Iowa City, IA 52242, USA. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins B-raf, Drug Resistance, Neoplasm, Single-Cell Analysis, Melanoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The evolution of therapeutic resistance is a major obstacle to the success of targeted oncology drugs. While both inter- and intratumoral heterogeneity limit our ability to detect resistant subpopulations that pre-exist or emerge during treatment, our ability to analyze tumors with single-cell resolution is limited. Here, we utilized a cell-based transposon mutagenesis method to identify mechanisms of BRAF inhibitor resistance in a model of cutaneous melanoma. This screen identified overexpression of NEDD4L and VGLL3 as significant drivers of BRAF inhibitor resistance in vivo. In addition, we describe a novel single-cell genomics profiling method to genotype thousands of individual cells within tumors driven by transposon mutagenesis. This approach revealed a surprising genetic diversity among xenograft tumors and identified recurrent co-occurring mutations that emerge within distinct tumor subclones. Taken together, these observations reveal an unappreciated genetic complexity that drives BRAF inhibitor resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins B-rafDrug Resistance, NeoplasmSingle-Cell AnalysisMelanomaProtein Kinase InhibitorsSkin NeoplasmsAnimalsHumansMiceGenomicsMutationCell Line, TumorXenograft Model Antitumor AssaysDNA Transposable Elements

Substanzen

Proto-Oncogene Proteins B-rafBRAF protein, humanProtein Kinase InhibitorsDNA Transposable Elements

Autor:innen und Institutionen

  • Department of Anatomy & Cell Biology, Carver College of Medicine, The University of Iowa, Iowa City, IA 52242, USA.
  • Interdisciplinary Graduate Program in Genetics, The University of Iowa, Iowa City, IA 52242, USA.
  • Medical Scientist Training Program, The University of Iowa, Iowa City, IA 52242, USA.
  • Holden Comprehensive Cancer Center, Carver College of Medicine, The University of Iowa, Iowa City, IA 52242, USA.
  • Department of Biology, The University of Iowa, Iowa City, IA 52242, USA.

ORCID-Profile: Jacob L Schillo, Adam J Dupuy

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health

Zitieren

APA

Schillo, J. L., Feddersen, C. R., Peplinski, R. M., Powell, L. S., Varzavand, A., Stipp, C. S., Riordan, J. D., & Dupuy, A. J. (2024). Single-cell genomics analysis reveals complex genetic interactions in an in vivo model of acquired BRAF inhibitor resistance. NAR Cancer, 6(1). https://doi.org/10.1093/narcan/zcad061

Vancouver

Schillo JL, Feddersen CR, Peplinski RM, Powell LS, Varzavand A, Stipp CS, et al. Single-cell genomics analysis reveals complex genetic interactions in an in vivo model of acquired BRAF inhibitor resistance. NAR Cancer. 2024;6(1). doi:10.1093/narcan/zcad061

BibTeX
@article{Schillo2024,
  author = {Schillo, Jacob L and Feddersen, Charlotte R and Peplinski, Rebekah M and Powell, Lexy S and Varzavand, Afshin and Stipp, Christopher S and Riordan, Jesse D and Dupuy, Adam J},
  title = {Single-cell genomics analysis reveals complex genetic interactions in an in vivo model of acquired BRAF inhibitor resistance},
  journal = {NAR Cancer},
  year = {2024},
  volume = {6},
  number = {1},
  doi = {10.1093/narcan/zcad061}
}
Kostenlos starten →